151213-46-6

Basic information

• Product Name: [S,S]-8-benzyl-2-methyl-2,8-diazabicyclo[4.3.0]nonane
• Synonyms: [S,S]-8-benzyl-2-methyl-2,8-diazabicyclo[4.3.0]nonane
• CAS NO: 151213-46-6
• Molecular Weight: 230.353
• Mol File: 151213-46-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [S,S]-8-benzyl-2-methyl-2,8-diazabicyclo[4.3.0]nonane(CAS DataBase Reference)
• NIST Chemistry Reference: [S,S]-8-benzyl-2-methyl-2,8-diazabicyclo[4.3.0]nonane(151213-46-6)
• EPA Substance Registry System: [S,S]-8-benzyl-2-methyl-2,8-diazabicyclo[4.3.0]nonane(151213-46-6)

Safety Data

• Hazardous Substances Data: 151213-46-6(Hazardous Substances Data)

Upstream product

• 151213-43-3 [R,R]-8-benzyl-2,8-diazabicyclo[4.3.0]nonane 
• 151213-39-7 (S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate 
• 50-00-0 formaldehyd 

Relevant articles and documents

Rifamycin analogs and uses thereof

The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, 4′- and/or 6′ halo and/or alkoxy analogs, and various 5′ substituents that incorporate a cyclic amine moiety.